Intermittent fasting has become an increasingly popular dietary approach, and many people with Type 2
diabetes wonder whether it can help improve their blood sugar control. The available research suggests
that, when done correctly and under medical guidance, intermittent fasting can offer meaningful benefits,
though it requires careful consideration for those on diabetes medication.

Read Also : Fatty Liver in Young Indians.

Intermittent fasting involves restricting eating to specific windows of time, with common approaches
including a twelve to sixteen hour overnight fast, or eating within a limited window during the day. During
the fasting period, insulin levels naturally decrease, allowing the body to access and burn stored fat for
energy, which can improve insulin sensitivity over time and support weight loss, a key factor in diabetes
reversal.
Several studies have shown that structured intermittent fasting can lead to improvements in fasting
glucose, HbA1c levels, and body weight in people with Type 2 diabetes, sometimes allowing for reduced
medication dosages under medical supervision. The extended fasting window also gives the pancreas
periodic rest from constant insulin production demands.
However, intermittent fasting is not appropriate for everyone with diabetes. Individuals taking insulin or
certain oral medications that lower blood sugar are at increased risk of hypoglycemia during fasting
periods, which can be dangerous if not carefully managed. Medication adjustments, closely supervised
by a physician, are often necessary before starting any fasting protocol.
Individuals with a history of eating disorders, pregnant or breastfeeding women, and those with certain
other medical conditions should generally avoid intermittent fasting unless specifically guided by their
healthcare provider.

At Dr. Rajender Lifestyle Clinic, intermittent fasting is only introduced when medically appropriate, with
careful monitoring and medication adjustment, ensuring patients can safely benefit from this approach as
part of a broader, personalized diabetes reversal strategy